I highly doubt one of the deals will get approved while the others will not. The Taiwan review is going to include Powertech and IMOS and potentially SPIL (they have basically said Tsinghua is dead). In addition it is my expectation that there are no deals approved at all which I think is actually good for us. It will allow 8150 to do a JV which will essentially give us all the revenue benefit without the dilution. I also think it is likely we get another 8150 buyback of similar size to the last one of 15 million shares.